Does Sildenafil Increase Exercise Performance in Air Pollution?
NCT00808912 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2010-06-23
Summary
The purpose of this study is to examine if the ingestion of a standard dose of sildenafil enhances the athletic performance of competitive athletes when exercising in a high pollutant environment verses a low air pollutant environment.
Conditions
- Pulmonary Hypertension
- Pulmonary Artery Pressure
- Exercise Performance
- Air Pollution
Interventions
- DRUG
-
sildenafil
sildenafil 50 mg ingested orally 1 hour prior to exercise testing
- OTHER
-
placebo
matching placebo for sildenafil 50 mg to be ingested orally 1 hour prior to exercise testing.
Sponsors & Collaborators
-
Marywood University
lead OTHER
Principal Investigators
-
Kenneth W Rundell, Ph.D. · Marywood University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2010-02-28
- Completion
- 2010-02-28
Countries
- United States
Study Locations
More Related Trials
-
Sildenafil for Chronic Obstructive Pulmonary Disease
NCT00104637 ·Status: COMPLETED ·Phase: PHASE2
-
Sildenafil and Exercise Capacity in Hypertension
NCT00599235 ·Status: COMPLETED ·Phase: NA
-
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
NCT00352482 ·Status: COMPLETED ·Phase: PHASE2
-
Sildenafil Exercise: Role of PDE5 Inhibition
NCT04039087 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension
NCT01889966 ·Status: COMPLETED ·Phase: PHASE4
-
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
NCT00492531 ·Status: TERMINATED ·Phase: PHASE2
-
Acute Hemodynamic Effects of Sildenafil in Patients With Severe Aortic Stenosis
NCT01060020 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease
NCT01948518 ·Status: COMPLETED ·Phase: NA
-
Effect of Regular Sildenafil on Blood Pressure and Arterial Function in Hypertension
NCT00317421 ·Status: COMPLETED ·Phase: PHASE2
-
To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks
NCT00946114 ·Status: COMPLETED
-
Study of Sildenafil in Patient With Heart Failure.
NCT00309816 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Sildenafil and Tadalafil on Skeletal Muscle and Perceptual Fatigue
NCT01661595 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
NCT00625079 ·Status: WITHDRAWN ·Phase: PHASE4
-
Exercise Oscillatory Breathing and Sildenafil in Heart Failure
NCT01185925 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Sildenafil in Advanced Heart Failure.
NCT00309790 ·Status: COMPLETED ·Phase: PHASE3
-
Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication
NCT02832570 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Viagra on Heart Function in Patients With Heart Failure
NCT00781508 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Sildenafil for Treatment of Urinary Incontinence
NCT02983461 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension
NCT00730067 ·Status: WITHDRAWN ·Phase: PHASE4
-
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
NCT00872170 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients
NCT01382368 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.
NCT00159913 ·Status: COMPLETED ·Phase: PHASE3
-
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
NCT04797286 ·Status: RECRUITING ·Phase: PHASE2
-
Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
NCT05061368 ·Status: RECRUITING ·Phase: PHASE2
-
Reversibility by Sildenafil of Exercise-Induced Abnormal Right Ventricular Pressure Response in ASD and VSD-Operated Patients
NCT00772135 ·Status: UNKNOWN ·Phase: NA